Syntheses of enantiomerically pure (R)- and (S)-bicalutamide
作者:Kenneth D James、Nnochiri N Ekwuribe
DOI:10.1016/s0040-4020(02)00560-4
日期:2002.7
The racemic antiandrogen bicalutamide is the leading antiandrogen used for the treatment of prostate cancer. The (R)-isomer possesses virtually all of the activity, but both isomers are metabolized by the liver. A convenient synthetic route to the active enantiomer would be an attractive option for patients who are hepatically impaired. We now demonstrate a rather short synthesis of (R)-bicalutamide, starting with a naturally occurring, chiral precursor. (C) 2002 Elsevier Science Ltd. All rights reserved.
ANDROGEN RECEPTOR ANTAGONISTS
申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
公开号:US20170101384A1
公开(公告)日:2017-04-13
Disclosed herein are compositions and methods for modulating the androgen receptor.
[EN] ANDROGEN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR DES ANDROGÈNES